G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday
Myriad Genetics to Host Investor Event on October 9, 2024
Myriad Genetics Insider Sold Shares Worth $1,285,851, According to a Recent SEC Filing
Insider Sale: Director Colleen Reitan Sells Shares of Myriad Genetics Inc (MYGN)
Sector Update: Health Care Stocks Softer Late Afternoon
Sector Update: Health Care
Leerink Partners Maintains Myriad Genetics(MYGN.US) With Buy Rating, Maintains Target Price $35
Leerink Partners analyst Puneet Souda maintains $Myriad Genetics(MYGN.US)$ with a buy rating, and maintains the target price at $35.According to TipRanks data, the analyst has a success rate of 34.9%
Myriad Genetics Discontinues Analysis on GeneSight Testing Due to Control Group Disparities
Maintained Buy Rating on Myriad Genetics Amid GeneSight Study Discontinuation
Myriad Genetics Shares Are Trading Lower After the Company Announced That It Discontinued the Second Part of Its Study Due to the Disparities Between the GeneSight Group and Control Group.
New Partnerships to Aid Myriad Genetics Stock Amid Macro Issues
Myriad Genetics Reports GeneSight Testing Study Progress
Express News | Myriad Genetics Inc: Has Determined to Discontinue Analysis for Part Two of Study
Express News | Myriad Genetics: Disparities Indicated Non-Genesight Control Group Was Not Viable Control for Part Two of Study of Genesight Testing - SEC Filing
Express News | Myriad Genetics: Identified Disparities Between Genesight & Non-Genesight Control Group in Baseline Hospital Resource Utilization & Costs in Analysis
Why Myriad Genetics (MYGN) Is a Top Momentum Stock for the Long-Term
Jefferies Upgrades Myriad Genetics(MYGN.US) to Buy Rating, Raises Target Price to $35
Jefferies analyst Brandon Couillard upgrades $Myriad Genetics(MYGN.US)$ to a buy rating, and adjusts the target price from $22 to $35.According to TipRanks data, the analyst has a success rate of 64.0
Wells Fargo Initiates Coverage On Myriad Genetics With Overweight Rating, Announces Price Target of $35
This Insider Has Just Sold Shares In Myriad Genetics
Insider Sale at Myriad Genetics Inc (MYGN): SVP, Chief of Staff Margaret Ancona Sells Shares